Nir Netzer
Director
Neurology
cellcure Neuroscience Ltd
Israel
Biography
Nir Netzer joined Cell Cure in 2012 and serves as the Director of Operations. He is responsible for the company’s operation, including the construction of Cell Cure’s new GMP facility for the production of clinical grade OpRegen. Previously, Dr. Netzer served as Cell Cure’s Preclinical Studies Manager and led the company’s IND enabling studies that serve as the basis for the ongoing clinical development of OpRegen in treating dry AMD. Prior to joining Cell Cure, Dr. Netzer served as a basic Science and Preclinical Studies Manager at Pluristem Ltd.
Research Interest
Dr. Netzer received his Ph.D. in Biotechnology from the Technion (Haifa, Israel), and was a postdoctoral fellow at the NIAID/NIH, where he studied viral immunology.
